Last updated: August 17, 2026

Examiner: CHENG, KAREN

Tech Center 1600 • Art Units: 1621 1622 1623 1626 1629

This examiner grants 76% of resolved cases

Performance Statistics

76.3%

Allow Rate

+16.3% vs TC avg

728

Total Applications

+27.1%

Interview Lift

768

Avg Prosecution Days

Based on 687 resolved cases, 2023–2026

2.6%

§101 Eligibility

20.3%

§102 Novelty

27.6%

§103 Obviousness

32.2%

§112 Clarity

App #	Title	Status	Assignee
17807292	PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF	Final Rejection	AbbVie Inc.
18715200	ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER	Non-Final OA	Vanderbilt University
17635631	ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF	Non-Final OA	University of Florida Research Foundation, Incorporated
18562243	APT1 and APT2 Inhibitors and Uses Thereof	Non-Final OA	Cornell University

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.